SCHEMBL24649889

SCHEMBL24649889

CC1(C)c2cc3c(cc2-c2c1cc(-c1ccc4ccccc4c1)c1c2oc2ccccc21)C(C)(C)c1cc(-c2ccc4ccccc4c2)c2oc4ccccc4c2c1-3

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.35
▸ ALOX5 P09917 1/20 0.32
▸ ALK Q9UM73 1/20 0.32
▸ MTOR P42345 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ GSTP1 P09211 1/20 0.31
▸ MIF P14174 1/20 0.31
▸ LPL P06858 1/20 0.31
▸ LIPG Q9Y5X9 1/20 0.31
▸ PRKDC P78527 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ HDAC4 P56524 1/20 0.30
▸ HDAC2 Q92769 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205524 0.96 GPR84 (0.35) GPR84ALOX5ALKMTORNPC1
SCHEMBL20205459 0.96 GPR84 (0.38) GPR84ALOX5ALKMTORNPC1
SCHEMBL20205714 0.92 GPR84 (0.34) GPR84ALOX5ALKNPC1CYP1A2
SCHEMBL24649618 0.91 PGR (0.36) GPR84ALOX5ALKLPLLIPG
SCHEMBL20205642 0.90 PGR (0.37) GPR84ALOX5ALKLPLLIPG
SCHEMBL20205579 0.89 TDP1 (0.34) NPC1CYP1A2RAB9ACYP1A1PRKDC
SCHEMBL20205423 0.89 ALK (0.30) ALKTDP1L3MBTL1
SCHEMBL20205583 0.89 PRKDC (0.32) ALOX5ALKPRKDCPGR
SCHEMBL20205741 0.89 CDC14B (0.36) ALOX5ALKNPC1RAB9ACYP1B1
SCHEMBL20205320 0.89 CDC14B (0.37) ALKNPC1CYP1A2RAB9ACYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND GPR84 3257/4885ALOX5 354/4885ALK 588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback